Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est

Beta Bionics (NASDAQ: BBNX ) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.